Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

SASH1 Activators

The potential activators for SASH1, a protein involved in signal transduction and cellular regulation, are primarily compounds that influence various signaling pathways and cellular processes. Compounds such as Epidermal Growth Factor (EGF) and Forskolin are believed to enhance the functional activity of SASH1 through their roles in modulating signal transduction and cellular metabolism. EGF, by activating various signaling pathways, may upregulate SASH1 activity in correlation with cell growth and differentiation processes, where SASH1 is implicated in modulating signal integration and response. Forskolin, through increasing intracellular cAMP levels, could influence a myriad of signaling cascades that interact with or regulate SASH1's function, perhaps leading to an enhanced role of SASH1 in these processes. Concurrently, Curcumin and Resveratrol, recognized for their broad biological impacts, might affect SASH1 indirectly by modulating inflammatory pathways, oxidative stress responses, or gene expression patterns. These compounds could create a cellular environment that necessitates or promotes the upregulation or activation of SASH1, facilitating its role in signal transduction, immune responses, or cellular homeostasis.

In parallel, a suite of inhibitors targeting key signaling molecules such as PD 98059, LY 294002, and U0126, which inhibit MEK, PI3K, and MEK1/2 respectively, may indirectly modulate the activity or expression of SASH1. By altering the signaling equilibrium, these inhibitors might induce compensatory cellular responses that involve SASH1, potentially enhancing its role or necessitating its activity to maintain cellular functionality and integrity. Similarly, SB 203580 and Wortmannin, as specific inhibitors of p38 MAPK and PI3K, could affect the cellular stress response or survival pathways, leading to a situation where SASH1's activity is upregulated or its role becomes more critical. Rapamycin and Metformin, affecting mTOR signaling and metabolic regulation respectively, might also indirectly impact SASH1's function as part of broader effects on cell growth, proliferation, and metabolic status. Collectively, these compounds underscore the potential to modulate SASH1 activity through various indirect mechanisms, reflecting its integrative role in cellular signaling networks and the complex nature of its regulation and function.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Increases intracellular cAMP, which can modulate various signaling pathways, potentially enhancing the signaling role of SASH1 in cells.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Known for its anti-inflammatory and antioxidant properties, curcumin might modulate signaling pathways and cellular stress responses in which SASH1 is implicated, potentially enhancing its activity or expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

As a compound known to influence various signaling pathways and cellular processes, resveratrol might enhance SASH1 activity indirectly through its effects on gene expression, apoptosis, and other cellular mechanisms.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

As a specific inhibitor of MEK, PD 98059 might alter downstream signaling pathways, potentially affecting those involving SASH1 and leading to its compensatory activation or increased expression in response to altered signaling dynamics.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that could affect various signaling pathways, including those related to cell survival and proliferation, potentially influencing SASH1's activity or stability indirectly.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, SP600125 could modulate signaling pathways in which SASH1 is involved, particularly those related to stress responses or apoptosis, potentially enhancing SASH1's role or expression as part of a cellular compensatory mechanism.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

As an inhibitor of p38 MAPK, SB 203580 might influence cellular stress and inflammatory responses, potentially affecting SASH1's activity or expression as part of the cellular adaptation to inhibited p38 activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A potent inhibitor of PI3K, wortmannin might affect SASH1 indirectly by altering PI3K-dependent signaling pathways, potentially leading to changes in cellular processes where SASH1 is involved.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Known to inhibit mTOR and affect cell growth and proliferation, rapamycin might influence SASH1's activity indirectly through its broad effects on cellular signaling and metabolism.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Often used for its antidiabetic effects, metformin might influence cellular signaling pathways related to metabolism and growth, potentially affecting SASH1's activity or expression indirectly through its role in these pathways.